Average Co-Inventor Count = 7.27
ph-index = 4
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Chugai Seiyaku Kabushiki Kaisha (6 from 947 patents)
2. Roche Palo Alto LLC (4 from 322 patents)
3. Hoffmann-la Roche Inc. (2 from 4,942 patents)
4. Syntex (u.s.a.) Inc. (1 from 932 patents)
5. Basilea Pharmaceutica Ag (1 from 68 patents)
14 patents:
1. 8648054 - 4'-substituted nucleoside derivatives as inhibitors of HCV RNA replication
2. 8362236 - Macrocyclic compound
3. 8193351 - HSP90 inhibitor
4. 8071567 - 4'-substituted nucleoside derivatives as inhibitors of HCV RNA replication
5. 8030496 - Intermediate compound for synthesis of viridiofungin a derivative
6. 7915232 - 4'-substituted nucleoside derivatives as inhibitors of HCV RNA replication
7. 7897783 - Intermediate compound for synthesis of viridiofungin a derivative
8. 7776918 - Remedy for viral disease
9. 7608601 - 4'-Substituted nucleoside derivatives as inhibitors of HCV RNA replication
10. 7378446 - Compound having anti-HCV activity and process for producing the same
11. 6784166 - 4′-substituted nucleoside derivatives as inhibitors of HCV RNA replication.
12. 6319933 - Azole derivatives
13. 5719291 - Cyclohexane derivatives
14. 5449785 - Cyclohexane derivatives